epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Advil PM
    ibuprofen/ diphenhydramine
  • remove Cleviprex
    clevidipine
  • remove EC-Naprosyn
    naproxen
  • remove Gleevec
    imatinib

multicheck MultiCheck Results - 5 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Advil PM (ibuprofen/ diphenhydramine) + EC-Naprosyn (naproxen)

Avoid/Use Alternative


ibuprofen + naproxen

avoid combo: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN, hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

Smiley face Smiley face Advil PM (ibuprofen/ diphenhydramine) + Cleviprex (clevidipine)

Monitor/Modify Tx


ibuprofen + clevidipine

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face Advil PM (ibuprofen/ diphenhydramine) + Gleevec (imatinib)

Monitor/Modify Tx


ibuprofen + imatinib

monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

Smiley face Smiley face Cleviprex (clevidipine) + EC-Naprosyn (naproxen)

Monitor/Modify Tx


clevidipine + naproxen

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face EC-Naprosyn (naproxen) + Gleevec (imatinib)

Monitor/Modify Tx


naproxen + imatinib

monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information